Xilio Therapeutics (XLO) EBIT Margin Growth (1y) (2025 - 2026)

Xilio Therapeutics (XLO) EBIT Margin Growth (1y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (1y) (Qtr)
1 Oculis Holding AG 65,899.61 Bn 65,899.33 Bn - -
2 Nanobiotix 1,933.82 Bn 1,933.76 Bn - -
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -
4 BeOne Medicines 471.67 Bn 466.88 Bn 1.35 Bn 1,552.00
5 Vertex Pharmaceuticals 122.32 Bn 115.07 Bn 2.59 Bn 1,536.00
6 Regeneron Pharmaceuticals 70.04 Bn 61.29 Bn 3.31 Bn -170.00
7 Belite Bio 62.06 Bn 62.06 Bn - -
8 Argenx Se 55.93 Bn 50.74 Bn 1.41 Bn 1,049.00
9 Alnylam Pharmaceuticals 37.55 Bn 34.54 Bn 959.66 Mn 1,997.00
10 Xilio Therapeutics 147.13 Mn -3.17 Mn - 36,116.00

Historic Data

Download Data
DateValue
Mar 31, 2026 36,116.00
Dec 31, 2025 70,406.00
Sep 30, 2025 64,220.00
Jun 30, 2025 44,613.00